CN1883670A - Liver-benefiting blood circulation-activating eyesight-improving tablet - Google Patents
Liver-benefiting blood circulation-activating eyesight-improving tablet Download PDFInfo
- Publication number
- CN1883670A CN1883670A CNA2006100821206A CN200610082120A CN1883670A CN 1883670 A CN1883670 A CN 1883670A CN A2006100821206 A CNA2006100821206 A CN A2006100821206A CN 200610082120 A CN200610082120 A CN 200610082120A CN 1883670 A CN1883670 A CN 1883670A
- Authority
- CN
- China
- Prior art keywords
- raw materials
- fructus
- blood circulation
- liver
- mumiyah
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a tablet for benefiting liver, promoting blood circulation and improving acuity of vision which comprises the raw materials of (by weight ratio) gypsum rubrum 90-130g, iron powder 60-90g, aragonite 60-90g, cane sugar 300-500g, starch 20-55g, magnesium stearate 15-35g, tabasheer, safflower, clove, chebula fruit, belleric terminalia fruit, emblic leafflower fruit, licorice root, multibanded krait, Epuisetum hiemale, caraway seeds, Meconopsis integrifolia, Mumiyah-asil each 20-40g.
Description
One, technical field: the invention belongs to the Tibetan medicine technical field, particularly a kind of tablet that has the liver benefiting, invigorates blood circulation, makes eye bright effect.
Two, technical background:
Existing Tibetan medicine has the liver benefiting, the medicament categories of the effect of invigorating blood circulation, make eye bright is less, a kind of dosage form of the watered pill is only arranged, the deficiency that it exists is that drug effect is undesirable, pill clothes back is slow in the gastrointestinal tract disintegrate, and effective ingredient discharges also slow, and it is slow promptly to be effect property, in addition owing to pharmaceutical factory equipment, workshop hygiene miscarriage, also can cause microbial contamination, it easily goes mouldy, poor stability.
Three, summary of the invention:
The objective of the invention is to develop a kind of tablet of new prescription at the prior art above shortcomings, it has effectively overcome the deficiencies in the prior art, and it has good drug efficacy, and medicine stability is good, do not go mouldy, medicine disintegrate in gastrointestinal tract is fast, is to imitate soon good absorbing, dosage is accurate, production cost is low, has effectively covered the bitterness and the stink of medicine discomfort, many advantages such as easily swallow.
Technical scheme is: this liver-benefiting eye-brightening sheet is to be made by following proportioning raw materials and manufacture method: (one), proportioning raw materials are: calcite 90~130g, Concretio Silicea Bambusae 20~40g, Flos Carthami 20~40g, Flos Caryophylli 20~40g, Fructus Chebulae 20~40g, Fructus Terminaliae Billericae 20~40g, Fructus Phyllanthi 20~40g, Radix Glycyrrhizae 20~40g, Bungarus Parvus 20~40g, Herba Equiseti Hiemalis 20~40g, caraway 20~40g, Herba meconopsis integrifoliae 20~40g, Mumiyah-asil 20~40g, iron powder 60~90g, aragonite 60~90g; Sucrose 300~500g, starch 20~55g, magnesium stearate 15~35g; (2), manufacture method is: earlier above-mentioned raw materials is prepared burden by said ratio, again Concretio Silicea Bambusae, Flos Carthami, Flos Caryophylli, Fructus Chebulae, Fructus Terminaliae Billericae, Fructus Phyllanthi, Radix Glycyrrhizae, Bungarus Parvus, Herba Equiseti Hiemalis, caraway, Herba meconopsis integrifoliae, 12 kinds of raw materials of Mumiyah-asil are decocted with water 2-3 time, the each decoction 1.5-3.5 hour, collecting decoction, filter and remove residue, filtrate concentrates deicer and makes extractum, calcite, iron powder, aragonite are ground into fine powder, with extractum, sucrose, mix homogeneously is made granule, and dry again back adds starch, the magnesium stearate compression molding gets product.Sucrose, starch, magnesium stearate are the raw material of pharmaceutical purpose, and all the other 15 clock raw materials are medical material clean, sanitary, that can be used as medicine, and wherein iron powder is the powder that can be used as medicine through artificial infusion.
Tablet of the present invention has good drug efficacy, and toxic and side effects is little, and medicine stability is good, does not go mouldy, and medicine disintegrate in gastrointestinal is fast, is to imitate soon, and good absorbing does not have bitterness and abnormal flavour when people take, and easily swallows processing technology science, advantage such as reasonable.When taking 2-3 time on the one, each 2-5 sheet.
Four, the specific embodiment:
Embodiment one: press calcite 90g, seven kinds of medical materials such as Concretio Silicea Bambusae, Flos Carthami, Flos Caryophylli, Fructus Chebulae, Fructus Terminaliae Billericae, Fructus Phyllanthi, Radix Glycyrrhizae are 20g, and five kinds of raw materials such as Bungarus Parvus, Herba Equiseti Hiemalis, caraway, Herba meconopsis integrifoliae, Mumiyah-asil are 40g, iron powder 90g, aragonite 90g, sucrose 500g, starch 55g, magnesium stearate 35g prepares burden, decoct 2 times during decoction, decocted 3.5 hours collecting decoction at every turn when decocting, filter and remove residue is made tablet by the manufacture method of technical scheme subsequently.
Embodiment two: press calcite 1.3kg, seven kinds of medical materials such as Concretio Silicea Bambusae, Flos Carthami, Flos Caryophylli, Fructus Chebulae, Fructus Terminaliae Billericae, Fructus Phyllanthi, Radix Glycyrrhizae are 0.4kg, and five kinds of raw materials such as Bungarus Parvus, Herba Equiseti Hiemalis, caraway, Herba meconopsis integrifoliae, Mumiyah-asil are 0.2kg, iron powder 0.6kg, aragonite 0.6kg, sucrose 3.0kg, starch 0.2kg, magnesium stearate 0.15kg prepares burden, decoct 3 times during decoction, decocted collecting decoction at every turn 1.5 hours, filter waste, tablet is made by the manufacture method of technical scheme in the back.
Claims (1)
1. liver-benefiting blood circulation-activating eyesight-improving tablet, it is characterized in that what it was made by following proportioning raw materials and manufacture method: (one), proportioning raw materials are: calcite 90~130g, Concretio Silicea Bambusae 20~40g, Flos Carthami 20~40g, Flos Caryophylli 20~40g, Fructus Chebulae 20~40g, Fructus Terminaliae Billericae 20~40g, Fructus Phyllanthi 20~40g, Radix Glycyrrhizae 20~40g, Bungarus Parvus 20~40g, Herba Equiseti Hiemalis 20~40g, caraway 20~40g, Herba meconopsis integrifoliae 20~40g, Mumiyah-asil 20~40g, iron powder 60~90g, aragonite 60~90g, sucrose 300~500g, starch 20~55g, magnesium stearate 15~35g; (2), manufacture method is: earlier above-mentioned raw materials is prepared burden by said ratio, again Concretio Silicea Bambusae, Flos Carthami, Flos Caryophylli, Fructus Chebulae, Fructus Terminaliae Billericae, Fructus Phyllanthi, Radix Glycyrrhizae, Bungarus Parvus, Herba Equiseti Hiemalis, caraway, Herba meconopsis integrifoliae, 12 kinds of raw materials of Mumiyah-asil are decocted with water 2~3 times, the each decoction 1.5~3.5 hours, collecting decoction, filter and remove residue, filtrate concentrating dewaters and makes extractum, calcite, iron powder, aragonite are ground into fine powder, make granule with extractum, sucrose mixing, dry again back adds starch, and the magnesium stearate compression molding gets product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2006100821206A CN1883670A (en) | 2006-05-27 | 2006-05-27 | Liver-benefiting blood circulation-activating eyesight-improving tablet |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2006100821206A CN1883670A (en) | 2006-05-27 | 2006-05-27 | Liver-benefiting blood circulation-activating eyesight-improving tablet |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1883670A true CN1883670A (en) | 2006-12-27 |
Family
ID=37582054
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2006100821206A Pending CN1883670A (en) | 2006-05-27 | 2006-05-27 | Liver-benefiting blood circulation-activating eyesight-improving tablet |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1883670A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109966328A (en) * | 2019-04-29 | 2019-07-05 | 白吉日木吐 | Ellagic acid and the extracting method of chebulinic acid and combinations thereof in a kind of myrobalan |
-
2006
- 2006-05-27 CN CNA2006100821206A patent/CN1883670A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109966328A (en) * | 2019-04-29 | 2019-07-05 | 白吉日木吐 | Ellagic acid and the extracting method of chebulinic acid and combinations thereof in a kind of myrobalan |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1840128A (en) | Medicine for treating cardiovascular disease | |
CN101297889B (en) | Chinese medicine preparation for treating foot-and-mouth disease and preparation method thereof | |
CN107801999A (en) | A kind of folium cortex eucommiae buccal tablet with vasorelaxation action | |
CN1170549C (en) | Process for preparing 'Qianjin' capsule to treat genopathy | |
CN101507697B (en) | Purple beautyberry mouth wash | |
CN1158087C (en) | Process for preparing 'Qianjin' capsule to treat ganopathy | |
CN103800795A (en) | Traditional Chinese medicine for treating gastric ulcer | |
CN109528868A (en) | A kind of Chinese medicine composition treats aphthae in preparation, the application in the drug of carbuncle swells furunculosis | |
CN101966261A (en) | Medicament for treating high blood pressure and preparation method thereof | |
CN1883670A (en) | Liver-benefiting blood circulation-activating eyesight-improving tablet | |
CN110870567B (en) | Edible granules for relieving gout and preparation method thereof | |
CN1883671A (en) | Liver-benefiting blood circulation-activating eyesight-improving granule | |
CN1203887C (en) | Traditional Chinese medicine for treating arthralgia and preparation process thereof | |
CN1517115A (en) | Chinese patent drug-Fuyan capsdule for treating chronic pelvic inflammation | |
CN102526462B (en) | Traditional Chinese medicine composition for treating tinnitus | |
CN1240655A (en) | Face-nursing stigma croci tea and its making method | |
CN107308254A (en) | Eight positives and preparation method thereof | |
CN103070337A (en) | Defaecation-promoting health-care food and preparation method thereof | |
CN101919983A (en) | Chinese materia medica preparation for treating gastritis chronic cholecystitis | |
CN101357221A (en) | Traditional Chinese medicine preparation for treating female coldness | |
CN100353987C (en) | Chinese medicinal preparation for treating acne | |
CN1813924A (en) | Eight-ingredient amur barberry bark capsule | |
CN103933267A (en) | Traditional Chinese medicinal composition for treating toothache and preparation method thereof | |
CN1292763C (en) | Chinese traditional medicine buccal tablets for preventing and treating caries and its preparation | |
CN1084198C (en) | Psoriasis treating Chinese medicine bolus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |